Moderna stock drops 12% after 177% surge: Here’s what Wall Street says about MRNA

Moderna stock falls 12% after a 177% surge as investors weigh the intismeran cancer vaccine win, future demand, pricing and other cancer trials.

from Business News: Get Latest Business News Today, Finance News, Share Market News, BSE/ NSE Update | Hindustan Times | Hindustan Times https://ift.tt/FXUby4Z